Governments, industry, and regulators are looking to use blockchain technology to improve the pharmaceutical supply chain. Blockchain creates an immutable record of all events, allowing for the safe and automated transfer of information. The cost of counterfeit drugs is significant, with up to 30% of antimalarials in sub-Saharan Africa estimated to be fake. Companies like Merck and Novartis are exploring blockchain’s use, and the US FDA has launched a pilot program. However, there are challenges to widespread adoption, such as a lack of common standards and legal barriers.
Group-IB’s Threat Intelligence and Defence Centre Equip Undergraduates with Sophisticated Cybersecurity Technologies to Boost Threat Analysis and Enhance Cyber Resilience for Campus Start-ups
Hey there from the heart of the San Francisco Bay Area! It’s an absolute pleasure to have you back again for our chat on some
